Komori
General Meetings of Shareholders4577Daito Pharmaceutical Co.,Ltd.Pharmaceuticals

Notice of Convocation of the 84th Ordinary General Meeting of Shareholders

At the 84th Annual General Meeting of Shareholders, the Company is submitting a proposal to elect 7 directors who are not Audit and Supervisory Committee Members, increasing the number from the current 5. Of the 7 candidates, 3 are new candidates and 2 are candidates for outside director.

Worth reading
48Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
2
Increase in number of directors
Wording
Definitive
How definitive the wording is.

Resolutions for the General Meeting of Shareholders

Annual (84th)
2026
Aug 27
Date and time10:30 a.m. (registration opens at 9:30 a.m.)28 days from this disclosure to the meeting
Matters for resolution1 item
  1. Election of 7 directors, excluding directors who are Audit and Supervisory Committee Members

Shareholder Proposal

Not disclosed

A shareholder proposal is a resolution submitted by a shareholder, rather than by the company.
Director nominee
7Nominees
3New
2Outside
Resolutions for the General Meeting of Shareholders
ItemDetails
Type of shareholders' meetingAnnual (84th)
Date and time27 August 2026, 10:30 a.m. (registration opens at 9:30 a.m.)
Matters for resolutionElection of 7 directors, excluding directors who are Audit and Supervisory Committee Members
Shareholder ProposalNot disclosed
Director nominee7 candidates (3 new, 2 outside)
Items this document does not state (1)
Percentage voting in favor

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To strengthen the management structure and further enhance corporate governance.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice of Convocation of the 84th Ordinary General Meeting of Shareholders | Daito Pharmaceutical Co.,Ltd. (4577) timely disclosure | Komori